Skip to main content
. 2020 Aug 17;26(4):367–382. doi: 10.1089/ten.teb.2020.0091

Table 2.

Summary of Differentiation Protocols for Human Pluripotent Stem Cell-Derived Pericytes

Cell source Differentiation methods Characterizations References
ESI-017 hESCs Spontaneous EB differentiation; EC medium CD146, CD105, PDGFRβ Greenwood-Goodwin et al.102
H9, I6 hESCs Spontaneous EB differentiation CD105, NG2, PDGFRβ, calponin, nestin Dar et al.103
C3, KTR13 hiPSCs
NL-HES4 hESCs Mesoderm induction: BMP4, Activin A, VEGF CD105, NG2, PDGFRβ, CD146, CD73, CD44, 30% yield; functional in cultured vascular plexus and zebrafish xenografts Orlova et al.; Iendaltseva et al.106,120,139
hiPSCs
H9 hESCs Mesoderm induction: 10% serum in α-MEM; then VEGF and SB431542 in EC medium NG2, PDGFRβ, CD73, CD44; studied the differences compared to vSMCs (SMA, SMMHC, calponin). ECM protein production, collagens and elastin, MMP2, 9, 14, migration and invasion Wanjare et al.108 with Jamieson et al.41
hiPSCs
H1 hESCs Mesoderm induction: BMP4, VEGF, FGF-2 in XVIVO-15 medium; later using SB431542; CD325-CD56+ cells were sorted using FACS The derived cells coexpressed common mesenchymal markers (CD73, CD105, CD90, and PDGFRβ) with a subset of cells defined as CD146hiCD73hi. Transcriptional similarity exists between hPSC-derived CD146++ and primary human CD146++ perivascular cells Chin et al.111
UCLA3 and UCLA6 hESCs
H1, H9 hESCs Mesoderm induction: coculture with OP9 stromal layer; or with BMP4, Activin A, and FGF-2; with BMP4, CHIR99021, PDGF-BB, and Activin A MBs differentiate into primitive PDGFRβ+CD271+CD73 mesenchymal progenitors, which give rise to proliferative PCs, SMCs, and MSCs. MB-derived PCs can be further specified to CD274+ capillary and DLK1+ arteriolar PCs Kumar et al.110
Blanchard et al.138
hiPSCs
H9 hESCs Mesoderm induction: MIM-mPCs NG2, PDGFRβ, CD13, CD146; brain specific markers VTN, FOXC1, FOXF2. FOXF2 is higher in ncPCs than mPCs
Functional assay: coculture with ECs forms tube-like structures; Wnt inhibition by DKK1 reduced PAX7 expression
Faal et al.115
hiPSCs from AD patients, lines AD 5, 6 (APOE4), 13, 14, 20, 22 (APOE3), 29 Neural crest induction: Wnt activation using CHIR99021, DMEM/F12 plus B27-ncPCs
H9 hESCs Neural crest induction: Wnt activation using CHIR99021, plus SB431542, FGF2, dorsomorphin, heparin in E6 medium; use MACS sorting and 10% FBS PDGFRβ, NG2, expressing CNN1, TAGLN, ANPEP, TBX18; brain mural markers: FOXF2, ZIC1, ABCC9, KCNJ8; functional assay: the derived cells assemble with vascular cord networks; induced BBB properties Stebbins et al.118
IMR90C4 and CS03n2 iPSCs

DKK1, Dickkopf WNT signaling pathway inhibitor 1; FBS, fetal bovine serum; MACS, magnetic-activated cell sorting; SMMHC, smooth muscle myosin heavy chain; PC, pericyte; BBB, blood–brain barrier; hiPSC, human induced pluripotent stem cell; hESC, human embryonic stem cell; FGF, fibroblast growth factor; MIM, mesodermal induction medium; BMP4, bone morphogenetic protein 4; PDGF-B, platelet-derived growth factor-B; FACS, fluorescence-activated cell sorting; VEGF, vascular endothelial growth factor; EC, endothelial cell; EB, embryoid body; PDGFRβ, platelet-derived growth factor receptor β; NG2, neural/glial antigen 2; vSMC, vascular smooth muscle cell; SMA, smooth muscle actin; hPSC, human pluripotent stem cell; MB, mesenchymoangioblast; MSC, mesenchymal stem cell; α-MEM, alpha-minimal essential medium; DMEM, Dulbecco's modified Eagle's medium.